Document Detail


A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo.
MedLine Citation:
PMID:  1126780     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Trimethylpsoralen, psoralen and 8-methoxypsoralen were adminstered in 10 mg dosage orally to 37, 29 and 23 patients with vitiligo. Complete improvement was noted in 8.9% and partial improvement was recorded in 59.5%. The overall results produced by trimethylpsoralen and psoralen were superior to those of 8-methoxypsoralen. There was no significant therapeutic difference noticed in regards to age, sex, duration and type of vitiligo.
Authors:
V N Sehgal
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  International journal of dermatology     Volume:  14     ISSN:  0011-9059     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  1975 Apr 
Date Detail:
Created Date:  1975-08-04     Completed Date:  1975-08-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  205-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coumarins / therapeutic use*
Female
Ficusin / therapeutic use*
Furans / therapeutic use
Humans
Male
Trioxsalen / therapeutic use*
Vitiligo / drug therapy*
Chemical
Reg. No./Substance:
0/Coumarins; 0/Furans; 3902-71-4/Trioxsalen; 66-97-7/Ficusin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Erythema multiforme infantum atrophicans.
Next Document:  Subgaleal hematoma in head injuries.